Conclusion The landscape of weight loss supplements, particularly those related to GLP-1, is complex and ever-evolving
It is recognized as the key to destroying fatty acid hydroperoxides ( Ferrozois, a new form of regulation of cell death, is primarily attributed to cellular lipid peroxidation (LPO) due to insufficient or absent GPX4 activity, ultimately causing cell death ( 2 O 2 ) to water (Ursini and Maiorino, 2020)
The LEADER Trial (Once-Daily Liraglutide) The LEADER trial primarily assessed the cardiovascular safety of once-daily liraglutide compared to placebo [26]
Mid-taper labs When you reach the halfway point of your taper, roughly when you have reduced to half your original maintenance dose, repeat the labs
Apart from this, the authors declare no conflict of interest